2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis

医学 雷公藤 随机对照试验 类风湿性关节炎 雷公藤 内科学 联合疗法 物理疗法 传统医学 替代医学 病理 有机化学 化学 糖苷
作者
Xuan Zhang,Jun Xia,Ying Jiang,David S. Pisetsky,Josef S Smolen,Rong Mu,Sheng‐Ming Dai,Michael E. Weinblatt,Tore Kristian Kvien,Juan Li,Thomas Dörner,Yu Zhang,Liwei Lu,Chengde Yang,Pingting Yang,Yuan Zhang,Chenchen Xu,Zhanzheng Zhao,Peter E. Lipsky
出处
期刊:Journal of Autoimmunity [Elsevier BV]
卷期号:142: 103148-103148 被引量:33
标识
DOI:10.1016/j.jaut.2023.103148
摘要

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints and produces pain, swelling, and stiffness. It has a lifetime prevalence of up to 1% worldwide. An extract of Tripterygium wilfordii Hook F (TwHF), a member of the Celastraceae herbal family widely available in south China, has been used for treatment of RA since 1960s.The current consensus practice guidance (CPG) aims to offer guidance on the application of TwHF in the clinical management of active RA. The CPG followed World Health Organisation (WHO)'s recommended process, carried out three systematic reviews to synthesize data from 19 randomised controlled trials (RCT) involving 1795 participants. We utilized Grading of Recommendations, Assessment, Development and Evaluation (GRADE) to evaluate certainty of evidence and derive recommendations. We rigorously followed The Appraisal of Guidelines for Research and Evaluation II (AGREE II) as conduct guides to minimise bias and promote transparency.There was no obvious difference between TwHF monotherapy and methotrexate (MTX) monotherapy on ACR20 (RCT = 2, N = 390, RR = 1.06, 95%CI 0.90-1.26, moderate certainty), ACR50 (RCT = 3, N = 419, RR = 1.03, 95%CI 0.80-1.34, moderate certainty), ACR70 (RCT = 2, N = 390, RR = 1.12, 95%CI 0.69-1.79, low certainty). TwHF monotherapy may be better than salicylazosulfapyridine monotherapy on ACR20 and the effect may be similar on ACR50 and ACR70. Seven RCTs compared MTX combined with TwHF versus MTX monotherapy, and the meta-analysis results favoured combination therapy group on ACR20 (RCT = 3, N = 470, RR = 1.44, 95%CI 1.28-1.62, moderate certainty), ACR50 (RCT = 4, N = 500, RR = 1.88, 95%CI 1.56-2.28, moderate certainty) and ACR70 (RCT = 2, N = 390, RR = 2.12, 95%CI 1.40-3.19, low certainty). We found no obvious difference between groups on critical safety outcomes, including infection (RCT = 3, N = 493, RR = 1.37, 95%CI 0.84-2.23), liver dysfunction (RCT = 5, N = 643, RR = 1.14, 95%CI 0.71-1.85), renal damage (RCT = 3, N = 450, RR = 2.20, 95%CI 0.50-9.72).Upon full review of the evidence, the guidance panel reached consensus on recommendations for the use of TwHF in people with active RA, either as monotherapy or as combination therapy with MTX.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
goodspeed完成签到,获得积分10
2秒前
2秒前
2秒前
3秒前
思源的应助被眼睛大的之卉采纳,获得20
4秒前
noahxinny发布了新的文献求助10
4秒前
5秒前
qy发布了新的文献求助10
5秒前
栗米椰发布了新的文献求助20
6秒前
结实的绿柳完成签到,获得积分10
6秒前
Hiker发布了新的文献求助10
7秒前
泥猴桃发布了新的文献求助30
7秒前
万能图书馆的应助被小生不才采纳,获得10
8秒前
Jasper的应助被鸭梨采纳,获得10
8秒前
洋洋完成签到,获得积分10
8秒前
8秒前
文静的翠彤完成签到 ,获得积分10
9秒前
万能图书馆的应助被洁净宝莹采纳,获得10
9秒前
INT发布了新的文献求助10
10秒前
麦粑块发布了新的文献求助10
10秒前
11秒前
无极微光的应助被CC采纳,获得20
12秒前
斯文败类的应助被脑花采纳,获得10
12秒前
13秒前
勤恳的板凳完成签到 ,获得积分10
13秒前
科研通AI6.2的应助被lhx采纳,获得10
14秒前
chen完成签到,获得积分10
14秒前
hml123发布了新的文献求助10
14秒前
cdercder的应助被栗子砸采纳,获得10
14秒前
15秒前
bobojiayou完成签到,获得积分10
15秒前
16秒前
知予完成签到 ,获得积分10
17秒前
笑点低的衬衫完成签到,获得积分10
18秒前
18秒前
19秒前
fairytaler的应助被arpege采纳,获得10
20秒前
孙子钊完成签到,获得积分10
21秒前
yuan完成签到 ,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239